Ratings
0
Nobody has rated this yet. Be the first!
Works
5
Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop
Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
Guidelines for the use and interpretation of assays for monitoring autophagy
Lists
0
